Trend Exploration Inc (TRDX)

[MarqueeGemFinder]

Payne78 and ALL - DD with TRDX intriguing

It is my opinion, that Dr. Jan Stahl is not missing, as he is the current CEO for UroSciences.- a privately held company hat sells products for urinary control problems.

Located in Glen Head- Long Island- and clearly not hiding - www.linkedin.com/pub/dr-jan-stahl/6b/37/7b6

DD provided yesterday, shows TRDX products and website still updated and active - and clearly generating Revenues.
In fact, his company still sells products with his NAME on them. The website has been updated and clearly maintained.
http://dentalkit.3dcartstores.com/

I came across this news article that got me thinking about how clean this L2 is- and how it appears there is no company dilution.
TRDX is located in Long Island, NY- and Dr. Stahl can be found there as well. He already had successful negotiations with Hospira- one of the worlds best.

Enjoy this read below... It's quite plausible that Dr Stahl STILL HAS HIS CONNECTIONS WITH HOSPIRA!!!!
-------------------------------------------------------------------------------------------
TRDX Prepares for Additional Revenue Stream From Its New Pharmaceutical Distribution Division

IMS Health Reports Pharmaceutical Market to Generate $1.1 Trillion in Sales by 2014

Press ReleaseSource: Trend Exploration, Inc. On Thursday February 3, 2011, 8:00 am

JERICHO, NY--(Marketwire - 02/03/11) - SciMeDent Health, Corp. f/k/a Trend Exploration, Inc. (Pinksheets:TRDX - News), is pleased to announce their wholly owned subsidiary Preferred Distribution, Inc. (Preferred), is on target to launch their new pharmaceutical distribution division by the second quarter of 2011.This division has already received approval by global pharmaceutical wholesaler Hospira, to distribute their products. Preferred's new pharmaceutical division will provide a third source of revenue for the Company. The pharmaceutical market is one of the fastest growing industries with long-term growth.

In an article dated April 20, 2010, IMS Health reported that the size of the global market for pharmaceuticals is expected to grow nearly $300 billion over the next five years, reaching $1.1 trillion in 2014. The 5 - 8 percent compound annual growth rate during this period reflects the impact of leading products losing patent protection in developed markets, as well as strong overall growth in the world's emerging countries.

Dr. Jan Stahl, TRDX CEO, stated: "

This is an exciting time for our company. Our new pharmaceutical division is anticipated to provide revenue growth in a rapidly growing industry. We have already received approval from global pharmaceutical wholesaler Hospira, to distribute their products. We anticipate receiving approval for distribution from other pharmaceutical wholesalers in the near-term."

About SciMeDent f/k/a Trend Exploration, Inc.(Pinksheets:TRDX - News)
SciMeDent (www.scimedenthealth.com) is a company focused on being a leading developer and marketer of products and services for medicine, dentistry and life sciences. SciMeDent plans to achieve growth initially through mergers and acquisitions.